Experience in eliminating the mother-to-child transmission of hepatitis B virus in China
Journal Title: Journal of Clinical Hepatology - Year 2024, Vol 40, Issue 11
Abstract
Reducing the mother-to-child transmission of hepatitis B virus （HBV） is crucial for achieving HBV elimination. Launched in July 2015 at the Great Hall of the People in Beijing， China， the “Zero Hepatitis B Mother-to-Child Transmission Project” （Shield Project） is a public welfare initiative integrating scientific prevention and applied research and aims to perform standardized management of pregnant women with hepatitis B using the mobile application of “Shield Project”， in order to further reduce or eliminate the mother-to-child transmission of HBV. At present， the Shield Project has expanded nationwide， offering detailed implementation strategies， successful practices， and reliable data to support the global effort to eliminate the mother-to-child transmission of HBV. This article introduces the implementation strategies and outcomes of the Shield Project in four representative cases， in order to provide strong evidence for further understanding and preventing the mother-to-child transmission of HBV.
Authors and Affiliations
Yali LUO, Wei WANG, Yuchen PAN, Jing JIANG, Hanlong ZHENG, Xueli WU, Hui CHEN, Shiben ZHU, Jinlin HOU
Keywords
Related Articles
- EP ID EP753515
- DOI 10.12449/JCH241103
- Views 16
- Downloads 1
Efficacy of des-γ-carboxy-prothrombin in the diagnosis of hepatocellular carcinoma and its association with the clinical features of hepatocellular carcinoma
[Objective] To investigate the value of des-γ-carboxy-prothrombin （DCP） in hepatocellular carcinoma （HCC）. [Methods] A retrospective analysis was performed for the clinical data of 179 HCC patients who were admitted...
Research advances in the pathogenesis of metabolic associated fatty liver disease
Metabolic associated fatty liver disease （MAFLD） is currently the most common liver disease around the world. MAFLD may easily progress to the adverse outcomes such as hepatitis， liver fibrosis， and liver cirrhosis，...
Risk factors for liver cancer in chronic hepatitis B patients and construction of a nomogram prediction model
[Objective] To investigate the risk factors for liver cancer in patients with chronic hepatitis B （CHB） in the Qidong Chronic Hepatitis B cohort， and to construct a nomogram model for predicting the risk of liver canc...
Guideline for diagnosis and treatment of liver failure （2024 version）
Liver failure is a severe clinical syndrome of liver disease with an extremely high mortality rate. Over the years， scholars worldwide have continuously investigated various aspects of liver failure， including its defi...
The mechanism of autophagy inducing drug resistance of hepatocellular carcinoma
Treatment resistance of hepatocellular carcinoma （HCC） is an important factor restricting its treatment outcome. Autophagy is a process involving multiple steps and targets and is closely associated with the proliferat...